Categories : Endocrine & Metabolic
Product Packaging : 10 / 30 tablets
Product Composition : 1000 mg + 1 mg, 1000 mg + 2 mg
Send MessageMetformin HCL ER + Glimepiride Tablets are a dual-action antidiabetic formulation designed to provide effective and sustained glycemic control in patients with type 2 diabetes mellitus. This combination integrates Metformin Hydrochloride in an extended-release (ER) format to reduce hepatic glucose production and enhance insulin sensitivity, along with Glimepiride, a sulfonylurea that stimulates pancreatic insulin secretion.
The extended-release delivery system of Metformin ensures gradual absorption and prolonged therapeutic activity, helping maintain stable blood glucose levels throughout the day. This combination is widely recommended for patients who require improved glycemic control beyond monotherapy, offering a balanced and effective approach to diabetes management.
Genliva Wellness LLP, Himatnagar, India, is a trusted metformin HCL ER glimepiride tablet manufacturer India, supplying high-quality formulations for domestic and international pharmaceutical markets with strong compliance to global quality standards.
Metformin HCl ER + Glimepiride Tablets are combination antidiabetic medications designed to provide sustained and effective blood glucose control in type 2 diabetes mellitus. The extended-release Metformin formulation supports prolonged therapeutic action and better glycemic stability.
These tablets are commonly prescribed for the treatment of type 2 diabetes mellitus in patients requiring combination therapy for improved glycemic control. They help manage elevated blood sugar levels along with diet and exercise.
Metformin HCl ER + Glimepiride Tablets provide dual-action glucose control with sustained therapeutic support and improved patient convenience for effective diabetic care.
